TY - JOUR
T1 - Circulatory response to volume expansion and transjugular intrahepatic portosystemic shunt in refractory ascites
T2 - Relationship with diastolic dysfunction
AU - Filì, Daniela
AU - Falletta, Calogero
AU - Luca, Angelo
AU - Hernandez Baravoglia, Cesar
AU - Clemenza, Francesco
AU - Miraglia, Roberto
AU - Scardulla, Cesare
AU - Tuzzolino, Fabio
AU - Vizzini, Giovanni
AU - Gridelli, Bruno
AU - Bosch, Jaime
PY - 2015/12/1
Y1 - 2015/12/1
N2 - Background: Cirrhotic cardiomyopathy may lead to heart failure in stressful circumstances, such as after transjugular intrahepatic portosystemic shunt (TIPS) placement. Aim: To examine whether acute volume expansion predicts haemodynamic changes after TIPS and elicits signs of impending heart failure. Methods: We prospectively evaluated refractory ascites patients (group A) and compensated cirrhotics (group B), who underwent echocardiography, NT-proBNP measurement, and heart catheterization before and after volume load; group A repeated measurements after TIPS. Results: 15 patients in group A (80% male; 54 ± 12.4 years) and 8 in group B (100% male; 56 ± 6.2 years) were enrolled. Echocardiography disclosed diastolic dysfunction in 30% and 12.5%, respectively. In group A, volume load and TIPS induced a significant increase in right atrial, mean pulmonary, capillary wedge pressure and cardiac index, and a decrease in systemic vascular resistance (respectively, 4.7 ± 2.8 vs. 9.9 ± 3.6 mmHg; 13.3 ± 3.5 vs. 21.9 ± 5.9 mmHg; 8.3 ± 3.4 vs. 15.4 ± 4.7 mmHg; 3.7 ± 0.7 vs. 4.6 ± 1 lt/min/m2; 961 ± 278 vs. 767 ± 285 dyn s cm-5; and 10.1 ± 3.3 vs. 14.2 ± 3.4 mmHg; 17.5 ± 4 vs. 25.2 ± 4.2 mmHg; 12.3 ± 4 vs. 19.3 ± 3.4 mmHg; 3.4 ± 0.8 vs. 4.5 ± 0.91 lt/min/m2; 779 ± 62 vs. 596 ± 199 dyn s cm-5, p < 0.001 for all pairs). At 24 h, cardiopulmonary pressures returned towards baseline. Conclusions: Acute volume expansion predicted haemodynamic changes immediately after TIPS. All patients had adequate haemodynamic adaptation to TIPS; none developed signs of heart failure.
AB - Background: Cirrhotic cardiomyopathy may lead to heart failure in stressful circumstances, such as after transjugular intrahepatic portosystemic shunt (TIPS) placement. Aim: To examine whether acute volume expansion predicts haemodynamic changes after TIPS and elicits signs of impending heart failure. Methods: We prospectively evaluated refractory ascites patients (group A) and compensated cirrhotics (group B), who underwent echocardiography, NT-proBNP measurement, and heart catheterization before and after volume load; group A repeated measurements after TIPS. Results: 15 patients in group A (80% male; 54 ± 12.4 years) and 8 in group B (100% male; 56 ± 6.2 years) were enrolled. Echocardiography disclosed diastolic dysfunction in 30% and 12.5%, respectively. In group A, volume load and TIPS induced a significant increase in right atrial, mean pulmonary, capillary wedge pressure and cardiac index, and a decrease in systemic vascular resistance (respectively, 4.7 ± 2.8 vs. 9.9 ± 3.6 mmHg; 13.3 ± 3.5 vs. 21.9 ± 5.9 mmHg; 8.3 ± 3.4 vs. 15.4 ± 4.7 mmHg; 3.7 ± 0.7 vs. 4.6 ± 1 lt/min/m2; 961 ± 278 vs. 767 ± 285 dyn s cm-5; and 10.1 ± 3.3 vs. 14.2 ± 3.4 mmHg; 17.5 ± 4 vs. 25.2 ± 4.2 mmHg; 12.3 ± 4 vs. 19.3 ± 3.4 mmHg; 3.4 ± 0.8 vs. 4.5 ± 0.91 lt/min/m2; 779 ± 62 vs. 596 ± 199 dyn s cm-5, p < 0.001 for all pairs). At 24 h, cardiopulmonary pressures returned towards baseline. Conclusions: Acute volume expansion predicted haemodynamic changes immediately after TIPS. All patients had adequate haemodynamic adaptation to TIPS; none developed signs of heart failure.
KW - Cirrhosis
KW - Echocardiography
KW - Heart failure
KW - Right heart catheterization
KW - Transjugular portosystemic shunt
UR - http://www.scopus.com/inward/record.url?scp=84983208727&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84983208727&partnerID=8YFLogxK
U2 - 10.1016/j.dld.2015.08.014
DO - 10.1016/j.dld.2015.08.014
M3 - Article
C2 - 26427586
AN - SCOPUS:84983208727
VL - 47
SP - 1052
EP - 1058
JO - Digestive and Liver Disease
JF - Digestive and Liver Disease
SN - 1590-8658
IS - 12
ER -